Drug intelligence / Profile preview

4-phenylfentanyl

Development stage
Unknown
Modality
Small Molecules
01

Overview

4-Phenylfentanyl is a synthetic opioid analgesic and a structural derivative of fentanyl. It was developed during research into potent opioid compounds, ultimately leading to the creation of super-potent analogues like carfentanil. Compared to fentanyl, 4‑Phenylfentanyl is approximately eight times more potent in animal analgesic tests. Like other fentanyl analogs, it acts primarily as an agonist at the mu-opioid receptor, producing strong pain relief but also significant risks such as respiratory depression and overdose. Its side effects are similar to those of other opioids and include itching, nausea, and potentially life-threatening respiratory depression[1][3][4]. The compound has no approved medical use and is considered illicit; it has been associated with fatalities in regions where novel synthetic opioids have emerged[3].

Other names
4-Phenyl fentanylN-(1-phenyethyl-4-phenylyl-piperidyl)-N-pheny-propanamide
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on 4-phenylfentanyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-phenylfentanyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call